Oncolytic Virotherapy (OVT) is an emerging area of cancer immunotherapy
that has shown promise as a therapeutic agent, leveraging genetically engineered replication-
competent viruses that kill cancer cells without harming normal cells. HSV-1 (T-VEC),
vaccinia, and adenoviruses. Immuno-Oncology Oncol Ther 2017; Mon...
Indu Arora, Shalu Attar, Priyanka Bhardwaj et al.· Clinical Cancer Drugs· 0 citations
Manuka honey is a promising multi-target adjunctive in treating breast cancer, especially the ER+ subtypes, which should be explored using well-designed clinical trials.
Bhumi Ruhil, Shafkat Hussain, Md Moidul Islam et al.· Clinical Cancer Drugs· 0 citations
The urgent need for reliable biomarkers, early diagnosis, and multidisciplinary disease-modifying strategies for future therapeutic interventions is highlighted, with particular emphasis on challenges associated with bench-to-bedside translation.
Jeewanjot Singh, Subhi Sharma, Prabhjot Singh et al.· 0 citations
The urgent need for reliable biomarkers, early diagnosis, and multidisciplinary disease-modifying strategies for future therapeutic interventions is highlighted, with particular emphasis on challenges associated with bench-to-bedside translation.
Jeewanjot Singh, Subhi Sharma, Prabhjot Singh et al.· Advances in Modern Biomedici...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.